Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Journal of Diabetes Investigation
|
September 12, 2018
Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan
Masahiko Sugimoto, Hideyuki Tsukitome, Fumiki Okamoto, et al.
Journal of Clinical Medicine
|
April 12, 2025
Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan
Masakazu Morioka, Yoshihiro Takamura, Shigeo Yoshida, et al.
Scientific Reports
|
December 18, 2020
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Masakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, et al.
Journal of Clinical Medicine
|
November 26, 2022
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan
Ryohei Komori, Yoshihiro Takamura, Yutaka Yamada, et al.
Pathogens (Basel, Switzerland)
|
April 3, 2021
Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial Endophthalmitis: A Multicenter Cohort Study from J-CREST
Hiroto Ishikawa, Kazutaka Uchida, Yoshio Takesue, et al.
Ocular Immunology and Inflammation
|
August 25, 2022
Risk Factors for Legal Blindness in 77 Japanese Patients with Endogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST
Takaaki Sugisawa, Hiroto Ishikawa, Kazutaka Uchida, et al.
Ocular Immunology and Inflammation
|
January 26, 2023
Risk Factors for Legal Blindness in 237 Japanese Patients with Exogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST
Ayano Yoshimura, Hiroto Ishikawa, Kazutaka Uchida, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Journal of Diabetes Investigation
|
September 12, 2018
Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan
Masahiko Sugimoto, Hideyuki Tsukitome, Fumiki Okamoto, et al.
Journal of Clinical Medicine
|
April 12, 2025
Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan
Masakazu Morioka, Yoshihiro Takamura, Shigeo Yoshida, et al.
Scientific Reports
|
December 18, 2020
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Masakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, et al.
Journal of Clinical Medicine
|
November 26, 2022
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan
Ryohei Komori, Yoshihiro Takamura, Yutaka Yamada, et al.
Pathogens (Basel, Switzerland)
|
April 3, 2021
Clinical Characteristics and Outcomes in 314 Japanese Patients with Bacterial Endophthalmitis: A Multicenter Cohort Study from J-CREST
Hiroto Ishikawa, Kazutaka Uchida, Yoshio Takesue, et al.
Ocular Immunology and Inflammation
|
August 25, 2022
Risk Factors for Legal Blindness in 77 Japanese Patients with Endogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST
Takaaki Sugisawa, Hiroto Ishikawa, Kazutaka Uchida, et al.
Ocular Immunology and Inflammation
|
January 26, 2023
Risk Factors for Legal Blindness in 237 Japanese Patients with Exogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST
Ayano Yoshimura, Hiroto Ishikawa, Kazutaka Uchida, et al.
Page
of 9